27
Chinese Research Breakthroughs and $12B Market Opportunity by 2030
The Chinese Academy of Sciences’ Shenyang Institute of Automation has developed a groundbreaking “rigid-flexible coupling” lower limb rehabilitation exoskeleton, marking another leap forward in a global market projected to grow at 28% CAGR to $12 billion by 2030, according to Grand View Research data.
Technology Breakthrough
- Innovation: Multi-joint “rigid-flexible coupling” design
- Application: Motor function rehabilitation for lower limb paralysis
- Advantage: Enhanced adaptability to human biomechanics
Market Outlook
| Segment | 2024 Market Size | 2030 Projection | CAGR |
|---|---|---|---|
| Medical Rehabilitation | $650M | $4.8B | 39% |
| Industrial | $720M | $4.2B | 34% |
| Military | $430M | $3.0B | 38% |
Key Listed Players
Xiangyu Medical (688626.SH)
- Product: Portable walking assist exoskeleton
- Status: Small-batch production
- Catalyst: Medical device certification expected 2024
Zhenjiang Co (603507.SH)
- Subsidiary: Hyperman Robotics (Shanghai)
- Focus: Bionic design & control algorithms
- Edge: Industrial exoskeleton patents
Growth Drivers
- Aging Populations: Global 65+ demographic to reach 1.6B by 2050
- Military Modernization: Soldier load-bearing requirements increasing
- Labor Shortages: Manufacturing sector adoption accelerating
- Tech Convergence: AI + sensor advancements enabling precision control
Investment Considerations
- Regulatory: Medical certification timelines critical
- Technical: Power density vs weight tradeoffs
- Market: B2B vs B2C adoption curves diverging
Note: Everbright Securities maintains overweight rating on medical exoskeleton segment, citing 5-7 year payback periods for rehabilitation centers.
Advertisements
Related topics:
Advertisements
